Chronic Kidney Disease: Challenges in Translational Medicine
- 28 October 2022
- book chapter
- Published by Springer Nature
- Vol. 2575, 61-75
Abstract
Chronic kidney disease (CKD) has long been recognized as a state of progressive decline in renal function. Morbidity and mortality are well correlated to the stage of renal function decline. Approximately one million deaths are estimated to be related to CKD worldwide. They are mostly associated with cardiovascular disease as a result of concurrent hypertension, accelerated atherosclerosis, and volume overload. Even with the best current treatment, disease progression is the general rule with a small fraction who reach CKD stage 5 requiring kidney transplantation or dialysis. Transplant patients show substantial reductions in mortality and cardiovascular events, as well as improvements in quality of life. However, the capacity of health systems to deliver kidney transplantation varies worldwide with worse indicators in low-income countries. Consequently, exploring novel and better therapeutic options for CKD is mandatory. Cell-based therapy is a promising strategy for treating CKD in preclinical models, and several clinical trials involving kidney disease exhibit a favorable safety profile. This chapter aims to provide an overview of CKD and the recent results of clinical trials of cell therapy in kidney diseases. Key words Kidney disease Cell therapy Stem cell Regenerative medicineKeywords
This publication has 51 references indexed in Scilit:
- Chronic kidney disease: global dimension and perspectivesThe Lancet, 2013
- ReferencesKidney International Supplements, 2013
- Introduction to Stem Cells and Regenerative MedicineRespiration, 2012
- Mesenchymal stem cells are a rescue approach for recovery of deteriorating kidney functionNephrology, 2012
- Chronic kidney disease after acute kidney injury: a systematic review and meta-analysisKidney International, 2012
- Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosusArthritis & Rheumatism, 2010
- Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical studyAnnals of the Rheumatic Diseases, 2010
- Genetic kidney diseasesThe Lancet, 2010
- Stage IV Chronic Kidney DiseaseNew England Journal of Medicine, 2010
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006